Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Closed Drug Transfer Systems Market Research Report 2025
Global Closed Drug Transfer Systems Market Research Report 2025
Industry: Medical Devices & Consumables
Published Date: 2025-08-01
Pages: 79 Pages
Report ld: 3439864
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Closed Drug Transfer Systems Market Size(US$)
CAGR 2025-2031
18.1%
Market Size,2031
USD 3,081
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,136 million
Market Forecast in 2031(Value)
US$ 3,081 million
CAGR
18.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Closed Drug Transfer Systems was valued at US$ 957 million in the year 2024 and is projected to reach a revised size of US$ 3081 million by 2031, growing at a CAGR of 18.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Closed Drug Transfer Systems competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
The rapid development of the closed-system drug transfer device market is driven by several key factors. First, there is a growing global emphasis on medical safety and sterile operations, particularly in hospitals, clinics, and other healthcare facilities. Preventing drug contamination and cross-infection has become a top priority. Closed-system drug transfer devices effectively ensure sterility during the transportation and transfer of drugs, reducing the risk of exposure to harmful substances for both healthcare workers and patients.
Second, advancements in biopharmaceuticals and personalized medicine have led to an increase in new types of drugs (such as cancer drugs and immunotherapy agents) that require highly controlled storage and transport conditions. These drugs are often highly active and sensitive, necessitating handling in controlled environments to ensure their stability and efficacy. Additionally, increasingly stringent regulations are compelling healthcare institutions to adopt more advanced transfer systems to comply with standards and guidelines, thereby avoiding potential legal risks and penalties.
In the future, the closed-system drug transfer device market will exhibit several significant trends. On one hand, technological innovation will continue to propel this field forward. For instance, the application of intelligent and automated technologies will make transfer devices more efficient, precise, and easier to manage, reducing the likelihood of human error. The integration of Internet of Things (IoT) technology allows these devices to monitor the status and environmental parameters of drugs in real-time, providing immediate feedback and alerts, which enhances supply chain transparency and traceability.
On the other hand, influenced by concepts of environmental protection and sustainability, manufacturers will place greater emphasis on the environmental performance and energy efficiency of their products. They will develop materials and technologies that are lighter, more energy-efficient, and easier to recycle. Furthermore, as the uneven distribution of global healthcare resources becomes more pronounced, the growing demand for telemedicine services will drive the use of closed-system drug transfer devices in remote areas and primary healthcare facilities, further expanding market coverage.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Closed Drug Transfer Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Closed Drug Transfer Systems.
The Closed Drug Transfer Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Closed Drug Transfer Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Closed Drug Transfer Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
Yukon Medical
JMS
Caragen Ltd.
Epic Medical
Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Closed Drug Transfer Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Closed Drug Transfer Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Closed Drug Transfer Systems Market Overview
1.1 Product Definition
1.2 Closed Drug Transfer Systems by Type
1.2.1 Global Closed Drug Transfer Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Closed Vial Access Devices
1.2.3 Closed Syringe Safety Devices
1.2.4 Closed Bag/Line Access Devices
1.3 Closed Drug Transfer Systems by Application
1.3.1 Global Closed Drug Transfer Systems Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Closed Drug Transfer Systems Market Size Estimates and Forecasts
1.4.1 Global Closed Drug Transfer Systems Revenue 2020-2031
1.4.2 Global Closed Drug Transfer Systems Sales 2020-2031
1.4.3 Global Closed Drug Transfer Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Closed Drug Transfer Systems Market Competition by Manufacturers
2.1 Global Closed Drug Transfer Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Closed Drug Transfer Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Closed Drug Transfer Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Closed Drug Transfer Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Closed Drug Transfer Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Closed Drug Transfer Systems, Product Type & Application
2.7 Global Key Manufacturers of Closed Drug Transfer Systems, Date of Enter into This Industry
2.8 Global Closed Drug Transfer Systems Market Competitive Situation and Trends
2.8.1 Global Closed Drug Transfer Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Closed Drug Transfer Systems Players Market Share by Revenue
2.8.3 Global Closed Drug Transfer Systems Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Closed Drug Transfer Systems Market Scenario by Region
3.1 Global Closed Drug Transfer Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Closed Drug Transfer Systems Sales by Region: 2020-2031
3.2.1 Global Closed Drug Transfer Systems Sales by Region: 2020-2025
3.2.2 Global Closed Drug Transfer Systems Sales by Region: 2026-2031
3.3 Global Closed Drug Transfer Systems Revenue by Region: 2020-2031
3.3.1 Global Closed Drug Transfer Systems Revenue by Region: 2020-2025
3.3.2 Global Closed Drug Transfer Systems Revenue by Region: 2026-2031
3.4 North America Closed Drug Transfer Systems Market Facts & Figures by Country
3.4.1 North America Closed Drug Transfer Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Closed Drug Transfer Systems Sales by Country (2020-2031)
3.4.3 North America Closed Drug Transfer Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Closed Drug Transfer Systems Market Facts & Figures by Country
3.5.1 Europe Closed Drug Transfer Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Closed Drug Transfer Systems Sales by Country (2020-2031)
3.5.3 Europe Closed Drug Transfer Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Closed Drug Transfer Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Closed Drug Transfer Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Closed Drug Transfer Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Closed Drug Transfer Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Closed Drug Transfer Systems Market Facts & Figures by Country
3.7.1 Latin America Closed Drug Transfer Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Closed Drug Transfer Systems Sales by Country (2020-2031)
3.7.3 Latin America Closed Drug Transfer Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Closed Drug Transfer Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Closed Drug Transfer Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Closed Drug Transfer Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Closed Drug Transfer Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Closed Drug Transfer Systems Sales by Type (2020-2031)
4.1.1 Global Closed Drug Transfer Systems Sales by Type (2020-2025)
4.1.2 Global Closed Drug Transfer Systems Sales by Type (2026-2031)
4.1.3 Global Closed Drug Transfer Systems Sales Market Share by Type (2020-2031)
4.2 Global Closed Drug Transfer Systems Revenue by Type (2020-2031)
4.2.1 Global Closed Drug Transfer Systems Revenue by Type (2020-2025)
4.2.2 Global Closed Drug Transfer Systems Revenue by Type (2026-2031)
4.2.3 Global Closed Drug Transfer Systems Revenue Market Share by Type (2020-2031)
4.3 Global Closed Drug Transfer Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Closed Drug Transfer Systems Sales by Application (2020-2031)
5.1.1 Global Closed Drug Transfer Systems Sales by Application (2020-2025)
5.1.2 Global Closed Drug Transfer Systems Sales by Application (2026-2031)
5.1.3 Global Closed Drug Transfer Systems Sales Market Share by Application (2020-2031)
5.2 Global Closed Drug Transfer Systems Revenue by Application (2020-2031)
5.2.1 Global Closed Drug Transfer Systems Revenue by Application (2020-2025)
5.2.2 Global Closed Drug Transfer Systems Revenue by Application (2026-2031)
5.2.3 Global Closed Drug Transfer Systems Revenue Market Share by Application (2020-2031)
5.3 Global Closed Drug Transfer Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD Medical, Inc
6.1.1 BD Medical, Inc Company Information
6.1.2 BD Medical, Inc Description and Business Overview
6.1.3 BD Medical, Inc Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Medical, Inc Closed Drug Transfer Systems Product Portfolio
6.1.5 BD Medical, Inc Recent Developments/Updates
6.2 Equashield
6.2.1 Equashield Company Information
6.2.2 Equashield Description and Business Overview
6.2.3 Equashield Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Equashield Closed Drug Transfer Systems Product Portfolio
6.2.5 Equashield Recent Developments/Updates
6.3 ICU Medical
6.3.1 ICU Medical Company Information
6.3.2 ICU Medical Description and Business Overview
6.3.3 ICU Medical Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ICU Medical Closed Drug Transfer Systems Product Portfolio
6.3.5 ICU Medical Recent Developments/Updates
6.4 Simplivia Healthcare Ltd.
6.4.1 Simplivia Healthcare Ltd. Company Information
6.4.2 Simplivia Healthcare Ltd. Description and Business Overview
6.4.3 Simplivia Healthcare Ltd. Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Simplivia Healthcare Ltd. Closed Drug Transfer Systems Product Portfolio
6.4.5 Simplivia Healthcare Ltd. Recent Developments/Updates
6.5 Corvida Medical
6.5.1 Corvida Medical Company Information
6.5.2 Corvida Medical Description and Business Overview
6.5.3 Corvida Medical Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Corvida Medical Closed Drug Transfer Systems Product Portfolio
6.5.5 Corvida Medical Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B. Braun Closed Drug Transfer Systems Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 Yukon Medical
6.7.1 Yukon Medical Company Information
6.7.2 Yukon Medical Description and Business Overview
6.7.3 Yukon Medical Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yukon Medical Closed Drug Transfer Systems Product Portfolio
6.7.5 Yukon Medical Recent Developments/Updates
6.8 JMS
6.8.1 JMS Company Information
6.8.2 JMS Description and Business Overview
6.8.3 JMS Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 JMS Closed Drug Transfer Systems Product Portfolio
6.8.5 JMS Recent Developments/Updates
6.9 Caragen Ltd.
6.9.1 Caragen Ltd. Company Information
6.9.2 Caragen Ltd. Description and Business Overview
6.9.3 Caragen Ltd. Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Caragen Ltd. Closed Drug Transfer Systems Product Portfolio
6.9.5 Caragen Ltd. Recent Developments/Updates
6.10 Epic Medical
6.10.1 Epic Medical Company Information
6.10.2 Epic Medical Description and Business Overview
6.10.3 Epic Medical Closed Drug Transfer Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Epic Medical Closed Drug Transfer Systems Product Portfolio
6.10.5 Epic Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Closed Drug Transfer Systems Industry Chain Analysis
7.2 Closed Drug Transfer Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Closed Drug Transfer Systems Production Mode & Process Analysis
7.4 Closed Drug Transfer Systems Sales and Marketing
7.4.1 Closed Drug Transfer Systems Sales Channels
7.4.2 Closed Drug Transfer Systems Distributors
7.5 Closed Drug Transfer Systems Customer Analysis
8 Closed Drug Transfer Systems Market Dynamics
8.1 Closed Drug Transfer Systems Industry Trends
8.2 Closed Drug Transfer Systems Market Drivers
8.3 Closed Drug Transfer Systems Market Challenges
8.4 Closed Drug Transfer Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Closed Drug Transfer Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Closed Drug Transfer Systems Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Closed Drug Transfer Systems Market Competitive Situation by Manufacturers in 2024
Table 4. Global Closed Drug Transfer Systems Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Closed Drug Transfer Systems Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Closed Drug Transfer Systems Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Closed Drug Transfer Systems Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Closed Drug Transfer Systems Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Closed Drug Transfer Systems, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Closed Drug Transfer Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Closed Drug Transfer Systems, Product Type & Application
Table 12. Global Key Manufacturers of Closed Drug Transfer Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Closed Drug Transfer Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Closed Drug Transfer Systems as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Closed Drug Transfer Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Closed Drug Transfer Systems Sales by Region (2020-2025) & (K Units)
Table 18. Global Closed Drug Transfer Systems Sales Market Share by Region (2020-2025)
Table 19. Global Closed Drug Transfer Systems Sales by Region (2026-2031) & (K Units)
Table 20. Global Closed Drug Transfer Systems Sales Market Share by Region (2026-2031)
Table 21. Global Closed Drug Transfer Systems Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Closed Drug Transfer Systems Revenue Market Share by Region (2020-2025)
Table 23. Global Closed Drug Transfer Systems Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Closed Drug Transfer Systems Revenue Market Share by Region (2026-2031)
Table 25. North America Closed Drug Transfer Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Closed Drug Transfer Systems Sales by Country (2020-2025) & (K Units)
Table 27. North America Closed Drug Transfer Systems Sales by Country (2026-2031) & (K Units)
Table 28. North America Closed Drug Transfer Systems Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Closed Drug Transfer Systems Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Closed Drug Transfer Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Closed Drug Transfer Systems Sales by Country (2020-2025) & (K Units)
Table 32. Europe Closed Drug Transfer Systems Sales by Country (2026-2031) & (K Units)
Table 33. Europe Closed Drug Transfer Systems Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Closed Drug Transfer Systems Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Closed Drug Transfer Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Closed Drug Transfer Systems Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Closed Drug Transfer Systems Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Closed Drug Transfer Systems Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Closed Drug Transfer Systems Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Closed Drug Transfer Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Closed Drug Transfer Systems Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Closed Drug Transfer Systems Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Closed Drug Transfer Systems Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Closed Drug Transfer Systems Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Closed Drug Transfer Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Closed Drug Transfer Systems Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Closed Drug Transfer Systems Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Closed Drug Transfer Systems Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Closed Drug Transfer Systems Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Closed Drug Transfer Systems Sales (K Units) by Type (2020-2025)
Table 51. Global Closed Drug Transfer Systems Sales (K Units) by Type (2026-2031)
Table 52. Global Closed Drug Transfer Systems Sales Market Share by Type (2020-2025)
Table 53. Global Closed Drug Transfer Systems Sales Market Share by Type (2026-2031)
Table 54. Global Closed Drug Transfer Systems Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Closed Drug Transfer Systems Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Closed Drug Transfer Systems Revenue Market Share by Type (2020-2025)
Table 57. Global Closed Drug Transfer Systems Revenue Market Share by Type (2026-2031)
Table 58. Global Closed Drug Transfer Systems Price (US$/Unit) by Type (2020-2025)
Table 59. Global Closed Drug Transfer Systems Price (US$/Unit) by Type (2026-2031)
Table 60. Global Closed Drug Transfer Systems Sales (K Units) by Application (2020-2025)
Table 61. Global Closed Drug Transfer Systems Sales (K Units) by Application (2026-2031)
Table 62. Global Closed Drug Transfer Systems Sales Market Share by Application (2020-2025)
Table 63. Global Closed Drug Transfer Systems Sales Market Share by Application (2026-2031)
Table 64. Global Closed Drug Transfer Systems Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Closed Drug Transfer Systems Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Closed Drug Transfer Systems Revenue Market Share by Application (2020-2025)
Table 67. Global Closed Drug Transfer Systems Revenue Market Share by Application (2026-2031)
Table 68. Global Closed Drug Transfer Systems Price (US$/Unit) by Application (2020-2025)
Table 69. Global Closed Drug Transfer Systems Price (US$/Unit) by Application (2026-2031)
Table 70. BD Medical, Inc Company Information
Table 71. BD Medical, Inc Description and Business Overview
Table 72. BD Medical, Inc Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. BD Medical, Inc Closed Drug Transfer Systems Product
Table 74. BD Medical, Inc Recent Developments/Updates
Table 75. Equashield Company Information
Table 76. Equashield Description and Business Overview
Table 77. Equashield Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Equashield Closed Drug Transfer Systems Product
Table 79. Equashield Recent Developments/Updates
Table 80. ICU Medical Company Information
Table 81. ICU Medical Description and Business Overview
Table 82. ICU Medical Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. ICU Medical Closed Drug Transfer Systems Product
Table 84. ICU Medical Recent Developments/Updates
Table 85. Simplivia Healthcare Ltd. Company Information
Table 86. Simplivia Healthcare Ltd. Description and Business Overview
Table 87. Simplivia Healthcare Ltd. Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Simplivia Healthcare Ltd. Closed Drug Transfer Systems Product
Table 89. Simplivia Healthcare Ltd. Recent Developments/Updates
Table 90. Corvida Medical Company Information
Table 91. Corvida Medical Description and Business Overview
Table 92. Corvida Medical Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Corvida Medical Closed Drug Transfer Systems Product
Table 94. Corvida Medical Recent Developments/Updates
Table 95. B. Braun Company Information
Table 96. B. Braun Description and Business Overview
Table 97. B. Braun Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. B. Braun Closed Drug Transfer Systems Product
Table 99. B. Braun Recent Developments/Updates
Table 100. Yukon Medical Company Information
Table 101. Yukon Medical Description and Business Overview
Table 102. Yukon Medical Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Yukon Medical Closed Drug Transfer Systems Product
Table 104. Yukon Medical Recent Developments/Updates
Table 105. JMS Company Information
Table 106. JMS Description and Business Overview
Table 107. JMS Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. JMS Closed Drug Transfer Systems Product
Table 109. JMS Recent Developments/Updates
Table 110. Caragen Ltd. Company Information
Table 111. Caragen Ltd. Description and Business Overview
Table 112. Caragen Ltd. Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Caragen Ltd. Closed Drug Transfer Systems Product
Table 114. Caragen Ltd. Recent Developments/Updates
Table 115. Epic Medical Company Information
Table 116. Epic Medical Description and Business Overview
Table 117. Epic Medical Closed Drug Transfer Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Epic Medical Closed Drug Transfer Systems Product
Table 119. Epic Medical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Closed Drug Transfer Systems Distributors List
Table 123. Closed Drug Transfer Systems Customers List
Table 124. Closed Drug Transfer Systems Market Trends
Table 125. Closed Drug Transfer Systems Market Drivers
Table 126. Closed Drug Transfer Systems Market Challenges
Table 127. Closed Drug Transfer Systems Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Closed Drug Transfer Systems
Figure 2. Global Closed Drug Transfer Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Closed Drug Transfer Systems Market Share by Type: 2024 & 2031
Figure 4. Closed Vial Access Devices Product Picture
Figure 5. Closed Syringe Safety Devices Product Picture
Figure 6. Closed Bag/Line Access Devices Product Picture
Figure 7. Global Closed Drug Transfer Systems Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Closed Drug Transfer Systems Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Closed Drug Transfer Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Closed Drug Transfer Systems Market Size (2020-2031) & (US$ Million)
Figure 13. Global Closed Drug Transfer Systems Sales (2020-2031) & (K Units)
Figure 14. Global Closed Drug Transfer Systems Average Price (US$/Unit) & (2020-2031)
Figure 15. Closed Drug Transfer Systems Report Years Considered
Figure 16. Closed Drug Transfer Systems Sales Share by Manufacturers in 2024
Figure 17. Global Closed Drug Transfer Systems Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Closed Drug Transfer Systems Players: Market Share by Revenue in Closed Drug Transfer Systems in 2024
Figure 19. Closed Drug Transfer Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Closed Drug Transfer Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Closed Drug Transfer Systems Sales Market Share by Country (2020-2031)
Figure 22. North America Closed Drug Transfer Systems Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Closed Drug Transfer Systems Sales Market Share by Country (2020-2031)
Figure 26. Europe Closed Drug Transfer Systems Revenue Market Share by Country (2020-2031)
Figure 27. Germany Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Closed Drug Transfer Systems Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Closed Drug Transfer Systems Revenue Market Share by Region (2020-2031)
Figure 34. China Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Closed Drug Transfer Systems Sales Market Share by Country (2020-2031)
Figure 44. Latin America Closed Drug Transfer Systems Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Closed Drug Transfer Systems Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Closed Drug Transfer Systems Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Closed Drug Transfer Systems Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Closed Drug Transfer Systems by Type (2020-2031)
Figure 54. Global Revenue Market Share of Closed Drug Transfer Systems by Type (2020-2031)
Figure 55. Global Closed Drug Transfer Systems Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Closed Drug Transfer Systems by Application (2020-2031)
Figure 57. Global Revenue Market Share of Closed Drug Transfer Systems by Application (2020-2031)
Figure 58. Global Closed Drug Transfer Systems Price (US$/Unit) by Application (2020-2031)
Figure 59. Closed Drug Transfer Systems Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Closed Drug Transfer Systems market?
The top companies in the global Closed Drug Transfer Systems market are BD Medical, Inc、Equashield、ICU Medical.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Closed Drug Transfer Systems market size from 2025 to 2031?
What was the global market size of Closed Drug Transfer Systems in 2025?
What was the global market size of Closed Drug Transfer Systems in 2031?
Related Reports
Global Closed Drug Transfer Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Closed Drug Transfer Systems market size was US$ 1136 million in 2025 and is forecast to reach a readjusted size of US$ 3583 million by 2032 with a CAGR of 18.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Closed Drug Transfer Systems Market Research Report 2026
The global Closed Drug Transfer Systems market was valued at US$ 1136 million in 2025 and is anticipated to reach US$ 3583 million by 2032, at a CAGR of 18.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 2900.00
(Single User License)
Closed Drug Transfer Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1136 million in 2025 and is projected to reach US$ 3583 million, growing at a CAGR of 18.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 98
USD 3950.00
(Single User License)
Global Closed Drug Transfer Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Closed Drug Transfer Systems market size was US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 78
USD 4250.00
(Single User License)
Global Closed Drug Transfer Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Closed Drug Transfer Systems market is projected to grow from US$ 957 million in 2024 to US$ 3081 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 144
USD 4900.00
(Single User License)
Closed Drug Transfer Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 3950.00
(Single User License)
Global Closed Drug Transfer Systems Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Closed Drug Transfer Systems was estimated to be worth US$ 1137 million and is forecast to reach approximately US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 106
USD 5900.00
(Single User License)
Closed Drug Transfer Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1137 million in 2024 and is forecast to a readjusted size of US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 71
USD 3950.00
(Single User License)
Global Closed Drug Transfer Systems Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published Date: 2024-04-17
Pages: 131
USD 5600.00
(Single User License)
Global Closed Drug Transfer Systems Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published Date: 2024-04-16
Pages: 135
USD 5900.00
(Single User License)
Global Closed Drug Transfer Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Closed Drug Transfer Systems market size was US$ 1136 million in 2025 and is forecast to reach a readjusted size of US$ 3583 million by 2032 with a CAGR of 18.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Closed Drug Transfer Systems Market Research Report 2026
The global Closed Drug Transfer Systems market was valued at US$ 1136 million in 2025 and is anticipated to reach US$ 3583 million by 2032, at a CAGR of 18.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 2900.00 (Single User License)Closed Drug Transfer Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1136 million in 2025 and is projected to reach US$ 3583 million, growing at a CAGR of 18.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 98
USD 3950.00 (Single User License)Global Closed Drug Transfer Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Closed Drug Transfer Systems market size was US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 78
USD 4250.00 (Single User License)Global Closed Drug Transfer Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Closed Drug Transfer Systems market is projected to grow from US$ 957 million in 2024 to US$ 3081 million by 2031, at a CAGR of 18.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 144
USD 4900.00 (Single User License)Closed Drug Transfer Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 3950.00 (Single User License)Global Closed Drug Transfer Systems Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Closed Drug Transfer Systems was estimated to be worth US$ 1137 million and is forecast to reach approximately US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 106
USD 5900.00 (Single User License)Closed Drug Transfer Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Closed Drug Transfer Systems was estimated to be worth US$ 1137 million in 2024 and is forecast to a readjusted size of US$ 3915 million by 2031 with a CAGR of 19.6% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 71
USD 3950.00 (Single User License)Global Closed Drug Transfer Systems Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published: 2024-04-17
Pages: 131
USD 5600.00 (Single User License)Global Closed Drug Transfer Systems Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
Published: 2024-04-16
Pages: 135
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now